Table 2.
Age (years) | n a/N b (%) preferring BETACONNECT |
---|---|
18–30 | 3/3 (100%) |
31–40 | 16/16 (100%) |
41–50 | 22/25 (88%) |
51–65 | 31/42 (74%) |
66–70 | 3/4 (75%) |
aNumber of patients in each age group who would rather use BETACONNECT than their current autoinjector
bTotal number of patients in each age group